NL154598B
(nl)
|
1970-11-10 |
1977-09-15 |
Organon Nv |
Werkwijze voor het aantonen en bepalen van laagmoleculire verbindingen en van eiwitten die deze verbindingen specifiek kunnen binden, alsmede testverpakking.
|
JPS5031249B1
(ro)
|
1970-12-17 |
1975-10-08 |
|
|
US3817837A
(en)
|
1971-05-14 |
1974-06-18 |
Syva Corp |
Enzyme amplification assay
|
JPS5710876B2
(ro)
|
1974-04-08 |
1982-03-01 |
|
|
US3939350A
(en)
|
1974-04-29 |
1976-02-17 |
Board Of Trustees Of The Leland Stanford Junior University |
Fluorescent immunoassay employing total reflection for activation
|
US3996345A
(en)
|
1974-08-12 |
1976-12-07 |
Syva Company |
Fluorescence quenching with immunological pairs in immunoassays
|
US4138498A
(en)
*
|
1976-12-07 |
1979-02-06 |
W. R. Grace & Co. |
Ruminant feed additive
|
US4275149A
(en)
|
1978-11-24 |
1981-06-23 |
Syva Company |
Macromolecular environment control in specific receptor assays
|
US4277437A
(en)
|
1978-04-05 |
1981-07-07 |
Syva Company |
Kit for carrying out chemically induced fluorescence immunoassay
|
JPS5557520A
(en)
|
1978-10-26 |
1980-04-28 |
Nisshin Flour Milling Co Ltd |
Preparation of carcinostatic substance
|
US4366241A
(en)
|
1980-08-07 |
1982-12-28 |
Syva Company |
Concentrating zone method in heterogeneous immunoassays
|
NL8300698A
(nl)
|
1983-02-24 |
1984-09-17 |
Univ Leiden |
Werkwijze voor het inbouwen van vreemd dna in het genoom van tweezaadlobbige planten; agrobacterium tumefaciens bacterien en werkwijze voor het produceren daarvan; planten en plantecellen met gewijzigde genetische eigenschappen; werkwijze voor het bereiden van chemische en/of farmaceutische produkten.
|
US4816567A
(en)
|
1983-04-08 |
1989-03-28 |
Genentech, Inc. |
Recombinant immunoglobin preparations
|
US4683202A
(en)
|
1985-03-28 |
1987-07-28 |
Cetus Corporation |
Process for amplifying nucleic acid sequences
|
DK122686D0
(da)
|
1986-03-17 |
1986-03-17 |
Novo Industri As |
Fremstilling af proteiner
|
FR2613624B1
(fr)
|
1987-04-10 |
1990-11-23 |
Roussy Inst Gustave |
Composition pharmaceutique, administrable par voie orale, destinee a reduire les effets des b-lactamines
|
DE68928665T2
(de)
|
1988-08-02 |
1998-11-12 |
Gastro Services Pty Ltd |
Behandlung von gastro-intestinalen krankheiten
|
US5443826A
(en)
|
1988-08-02 |
1995-08-22 |
Borody; Thomas J. |
Treatment of gastro-intestinal disorders with a fecal composition or a composition of bacteroides and E. Coli
|
KR100225087B1
(ko)
|
1990-03-23 |
1999-10-15 |
한스 발터라벤 |
피타아제의 식물내 발현
|
ES2068586T5
(es)
|
1990-05-09 |
2004-12-01 |
Novozymes A/S |
Una preparacion de celulasa que comprende una enzima endoglucanasa.
|
GB9107305D0
(en)
|
1991-04-08 |
1991-05-22 |
Unilever Plc |
Probiotic
|
EP0581171B1
(en)
|
1992-07-20 |
1998-02-04 |
Kabushiki Kaisha Yakult Honsha |
Species-specific oligonucleotides for bifidobacteria and a method of detection using the same
|
DK0673429T3
(da)
|
1992-12-10 |
2002-10-07 |
Dsm Nv |
Fremstilling af heterologe proteiner i filamentøse svampe
|
US5741665A
(en)
|
1994-05-10 |
1998-04-21 |
University Of Hawaii |
Light-regulated promoters for production of heterologous proteins in filamentous fungi
|
US5599795A
(en)
|
1994-08-19 |
1997-02-04 |
Mccann; Michael |
Method for treatment of idiopathic inflammatory bowel disease (IIBD)
|
AUPM823094A0
(en)
|
1994-09-16 |
1994-10-13 |
Goodman Fielder Limited |
Probiotic compositions
|
AUPM864894A0
(en)
|
1994-10-07 |
1994-11-03 |
Borody, Thomas Julius |
Treatment of bowel-dependent neurological disorders
|
RU2078815C1
(ru)
|
1995-01-17 |
1997-05-10 |
Московский научно-исследовательский институт эпидемиологии и микробиологии им.Г.Н.Габричевского |
Штамм бактерий bifidobacterium breve, используемый для получения бактерийных лечебно-профилактических бифидосодержащих препаратов
|
JPH08259450A
(ja)
|
1995-03-17 |
1996-10-08 |
Nichinichi Seiyaku Kk |
インターフェロン産生増強剤
|
US6861053B1
(en)
|
1999-08-11 |
2005-03-01 |
Cedars-Sinai Medical Center |
Methods of diagnosing or treating irritable bowel syndrome and other disorders caused by small intestinal bacterial overgrowth
|
CA2232001C
(en)
*
|
1995-09-15 |
2002-12-10 |
Dale N. Gerding |
Methods and compositions for prevention and treatment of clostridium difficile-associated diseases
|
AUPN698495A0
(en)
|
1995-12-06 |
1996-01-04 |
Pharma Pacific Pty Ltd |
Improved therapeutic formulation and method
|
SE508045C2
(sv)
|
1996-02-26 |
1998-08-17 |
Arla Ekonomisk Foerening |
Adhesionsinhibitorer, preparat innehållande desamma och förfarande för framställning därav
|
ATE407700T1
(de)
|
1996-03-20 |
2008-09-15 |
Univ New South Wales |
Veränderung der mikrobenflora im verdauungstrakt
|
AUPN881396A0
(en)
|
1996-03-20 |
1996-04-18 |
Arnott's Biscuits Limited |
Enhancement of microbial colonization of the gastrointestinal tract
|
WO1997035956A1
(en)
|
1996-03-27 |
1997-10-02 |
Novo Nordisk A/S |
Alkaline protease deficient filamentous fungi
|
US6033864A
(en)
|
1996-04-12 |
2000-03-07 |
The Regents Of The University Of California |
Diagnosis, prevention and treatment of ulcerative colitis, and clinical subtypes thereof, using microbial UC pANCA antigens
|
WO1998043081A1
(en)
|
1997-03-26 |
1998-10-01 |
Ligand Pharmaceuticals Incorporated |
Treatment of gastrointestinal disease with ppar modulators
|
SE511524C2
(sv)
|
1997-06-02 |
1999-10-11 |
Essum Ab |
Lactobacillus casei rhamnosus-stam samt farmaceutisk beredning för bekämpning av patogena tarmbakterier
|
US5925657A
(en)
|
1997-06-18 |
1999-07-20 |
The General Hospital Corporation |
Use of PPARγ agonists for inhibition of inflammatory cytokine production
|
AUPO758297A0
(en)
|
1997-06-27 |
1997-07-24 |
Rowe, James Baber |
Control of acidic gut syndrome
|
US5951977A
(en)
|
1997-10-14 |
1999-09-14 |
The United States Of America, As Represented By The Secretary Of Agriculture |
Competitive exclusion culture for swine
|
US6652866B1
(en)
|
1997-10-14 |
2003-11-25 |
David W. Hertha |
Method for treating diseases of fungal, yeast, and prion protein etiology
|
IT1298918B1
(it)
|
1998-02-20 |
2000-02-07 |
Mendes Srl |
Uso di batteri dotati di arginina deiminasi per indurre apoptosi e/o ridurre una reazione infiammatoria e composizioni farmaceutiche
|
DE19826928A1
(de)
|
1998-06-17 |
1999-12-23 |
Novartis Consumer Health Gmbh |
Arzneimittel, lebensfähige anaerobe Bakterien enthaltend, die die Sulfatreduktion sulfatreduzierender Bakterien hemmen
|
ID29150A
(id)
|
1999-01-15 |
2001-08-02 |
Entpr Ireland Cs |
Penggunaan lactobacillus salivarius
|
US7090973B1
(en)
|
1999-04-09 |
2006-08-15 |
Oscient Pharmaceuticals Corporation |
Nucleic acid sequences relating to Bacteroides fragilis for diagnostics and therapeutics
|
AUPQ137699A0
(en)
*
|
1999-07-02 |
1999-07-22 |
University Of New England, The |
Control of acidosis
|
US6417212B1
(en)
|
1999-08-27 |
2002-07-09 |
Eli Lilly & Company |
Modulators of peroxisome proliferator activated receptors
|
EP1257176B1
(en)
|
2000-02-08 |
2008-04-30 |
DSM IP Assets B.V. |
Use of acid-stable proteases in animal feed
|
FR2808689B1
(fr)
|
2000-05-11 |
2004-09-03 |
Agronomique Inst Nat Rech |
Utilisation de souches acetogenes hydrogenotrophes pour la prevention ou le traitement de troubles digestifs
|
US20040170617A1
(en)
*
|
2000-06-05 |
2004-09-02 |
Finegold Sydney M. |
Method of treating diseases associated with abnormal gastrointestinal flora
|
US20020013270A1
(en)
*
|
2000-06-05 |
2002-01-31 |
Bolte Ellen R. |
Method for treating a mental disorder
|
AUPQ899700A0
(en)
|
2000-07-25 |
2000-08-17 |
Borody, Thomas Julius |
Probiotic recolonisation therapy
|
AU2002226984A1
(en)
|
2000-11-27 |
2002-06-03 |
Astrazeneca Ab |
Method for studying the effects of commensal microflora on mammalian intestine and treatments of gastrointestinal-associated disease based thereon
|
BR0116788A
(pt)
*
|
2000-12-21 |
2004-02-03 |
Nestle Sa |
Cepa de lactobacillus que produz levano e seu uso em produtos alimentìcios para seres humanos ou para animais de estimação
|
DE10101793A1
(de)
|
2001-01-17 |
2002-08-01 |
Manfred Nilius |
Verwendung von SLPI zur Behandlung chronisch-entzündlicher Darmerkrankungen
|
EP1227152A1
(en)
|
2001-01-30 |
2002-07-31 |
Société des Produits Nestlé S.A. |
Bacterial strain and genome of bifidobacterium
|
KR100437497B1
(ko)
|
2001-03-07 |
2004-06-25 |
주식회사 프로바이오닉 |
로타바이러스 및 유해 미생물 억제 활성을 가지는 신규내산성 락토바실러스 루테리 프로바이오-16 및 이를함유하는 생균활성제
|
EP1243273A1
(en)
|
2001-03-22 |
2002-09-25 |
Societe Des Produits Nestle S.A. |
Composition comprising a prebiotic for decreasing infammatory process and abnormal activation of non-specific immune parameters
|
WO2002080947A1
(fr)
|
2001-04-06 |
2002-10-17 |
Kyodoken Institute For Animal Science Research & Development |
Compositions contenant une bacterie pouvant convertir de l'acide lactique en acide butyrique, et methode utilisant ces compositions pour prevenir ou traiter l'hyperlactacidemie dans le systeme digestif ou le cancer du colon
|
ATE463505T1
(de)
|
2001-04-20 |
2010-04-15 |
Inst Systems Biology |
Toll-ähnlichen-rezeptor-5-liganden und verwendungsverfahren
|
EP1260227A1
(en)
|
2001-05-23 |
2002-11-27 |
Societe Des Produits Nestle S.A. |
Lipoteichoic acid from lactic acid bacteria and its use to modulate immune responses mediated by gram-negative bacteria, potential pathogenic gram-positive bacteria
|
US20030092163A1
(en)
|
2001-07-26 |
2003-05-15 |
Collins John Kevin |
Probiotic bifidobacterium strains
|
US20040241149A1
(en)
|
2001-09-05 |
2004-12-02 |
Claudio De Simone |
Use of unmethylatd cpg
|
GB0127916D0
(en)
|
2001-11-21 |
2002-01-16 |
Rowett Res Inst |
Method
|
US20050037955A1
(en)
|
2001-11-27 |
2005-02-17 |
Hooper Laura Virginia |
Therapeutic protein and treatments
|
CA2860702C
(en)
|
2001-12-17 |
2019-02-26 |
Corixa Corporation |
Compositions and methods for the therapy and diagnosis of inflammatory bowel disease
|
US7101565B2
(en)
|
2002-02-05 |
2006-09-05 |
Corpak Medsystems, Inc. |
Probiotic/prebiotic composition and delivery method
|
DE10206995B4
(de)
|
2002-02-19 |
2014-01-02 |
Orthomol Pharmazeutische Vertriebs Gmbh |
Mikronährstoffkombinationsprodukt mit Pro- und Prebiotika
|
JP2003261453A
(ja)
|
2002-03-11 |
2003-09-16 |
Nippon Berumu Kk |
E.フェカリスからなる抗腫瘍剤及び放射線防護剤
|
EP1565547B2
(en)
|
2002-06-28 |
2012-09-19 |
Biosearch S.A. |
Probiotic strains, a process for the selection of them, compositions thereof, and their use
|
US20040005304A1
(en)
*
|
2002-07-08 |
2004-01-08 |
Mak Wood, Inc. |
Novel compositions and methods for treating neurological disorders and associated gastrointestinal conditions
|
GB0307026D0
(en)
|
2003-03-27 |
2003-04-30 |
Rowett Res Inst |
Bacterial supplement
|
US20040230963A1
(en)
*
|
2003-05-12 |
2004-11-18 |
Rothman Michael A. |
Method for updating firmware in an operating system agnostic manner
|
EP1481681A1
(en)
|
2003-05-30 |
2004-12-01 |
Claudio De Simone |
Lactic acid bacteria combination and compositions thereof
|
GB0316915D0
(en)
|
2003-07-18 |
2003-08-20 |
Glaxo Group Ltd |
Compounds
|
AU2003247193A1
(en)
|
2003-07-23 |
2005-02-04 |
M.D.Lab Corp. |
Acid tolerant probiotic lactobacillus plantarum probio-38 that can suppress the growth of pathogenic microorganism and tge coronavirus
|
US7485325B2
(en)
|
2003-08-06 |
2009-02-03 |
Gayle Dorothy Swain |
Animal food supplement compositions and methods of use
|
JP4683881B2
(ja)
|
2003-08-27 |
2011-05-18 |
有限会社アーク技研 |
抗腫瘍活性剤
|
US8192733B2
(en)
|
2003-08-29 |
2012-06-05 |
Cobb & Associates |
Probiotic composition useful for dietary augmentation and/or combating disease states and adverse physiological conditions
|
EP2226072A1
(en)
*
|
2003-08-29 |
2010-09-08 |
Aton Pharma, Inc. |
Combinations of suberoylanilide hydroxamic acid and antimetbolic agents for treating cancer
|
US20050163764A1
(en)
|
2003-09-22 |
2005-07-28 |
Yale University |
Treatment with agonists of toll-like receptors
|
GB0323039D0
(en)
|
2003-10-01 |
2003-11-05 |
Danisco |
Method
|
PT1675481E
(pt)
|
2003-10-24 |
2009-01-02 |
Nutricia Nv |
Composição sinbiótica para bebés
|
US20050239706A1
(en)
|
2003-10-31 |
2005-10-27 |
Washington University In St. Louis |
Modulation of fiaf and the gastrointestinal microbiota as a means to control energy storage in a subject
|
EP1696941A1
(en)
|
2003-12-17 |
2006-09-06 |
N.V. Nutricia |
Lactic acid producing bacteria and lung function
|
ES2235642B2
(es)
|
2003-12-18 |
2006-03-01 |
Gat Formulation Gmbh |
Proceso de multi-microencapsulacion continuo para la mejora de la estabilidad y almacenamiento de ingredientes biologicamente activos.
|
CN1954066A
(zh)
|
2004-03-22 |
2007-04-25 |
美国政府健康及人类服务部 |
细胞和病毒灭活
|
WO2005107381A2
(en)
|
2004-05-07 |
2005-11-17 |
Hans-Gustaf Ljunggren |
Use of flagellin as an adjuvant for vaccine
|
PE20060426A1
(es)
|
2004-06-02 |
2006-06-28 |
Schering Corp |
DERIVADOS DE ACIDO TARTARICO COMO INHIBIDORES DE MMPs, ADAMs, TACE Y TNF-alfa
|
US7638513B2
(en)
|
2004-06-02 |
2009-12-29 |
Schering Corporation |
Compounds for the treatment of inflammatory disorders
|
EP1765391B1
(en)
|
2004-06-07 |
2013-03-06 |
Qu Biologics Inc |
Bacterial compositions for the treatment of cancer
|
ES2523018T3
(es)
|
2004-06-30 |
2014-11-20 |
Nutrition Sciences N.V./S.A. |
Ácidos grasos de cadena media aplicables como agentes anti-microbianos
|
ATE361101T1
(de)
|
2004-08-24 |
2007-05-15 |
Nutricia Nv |
Nahrungszusammensetzung die unverdauliche oligosaccharide enthält
|
US20060062773A1
(en)
|
2004-09-21 |
2006-03-23 |
The Procter & Gamble Company |
Compositions for maintaining and restoring normal gastrointestinal flora
|
JP5371169B2
(ja)
|
2004-09-24 |
2013-12-18 |
コンビ株式会社 |
薬剤耐性菌感染防除剤
|
KR100468522B1
(ko)
|
2004-10-12 |
2005-01-31 |
주식회사 프로바이오닉 |
코로나바이러스와 돼지 써코바이러스 2형의 생육을 억제하는 신규한 내산성 프로바이오틱 엔테로코커스훼시움 프로바이오-63
|
US20060115465A1
(en)
|
2004-10-29 |
2006-06-01 |
Macfarlane George |
Treatment of gastrointestinal disorders
|
ITMI20042189A1
(it)
|
2004-11-16 |
2005-02-16 |
Anidral Srl |
Composizione a base di batteri probiotici e suo uso nella prevenzione e-o nel trattamento di patologie e-o infezioni respiratorie e nel miglioramento della funzionalita' intestinale
|
US20060194241A1
(en)
|
2005-02-28 |
2006-08-31 |
Jan Knol |
Lactobacillus specific probes
|
WO2006102536A2
(en)
|
2005-03-23 |
2006-09-28 |
University Of Southern California |
Treatment of disease conditions through modulation of hydrogen sulfide produced by small intestinal bacterial overgrowth
|
WO2006102350A1
(en)
|
2005-03-23 |
2006-09-28 |
Washington University In St. Louis |
The use of archaea to modulate the nutrient harvesting functions of the gastrointestinal microbiota
|
JP2006265212A
(ja)
|
2005-03-25 |
2006-10-05 |
Institute Of Physical & Chemical Research |
Il−21産生誘導剤
|
US20100233312A9
(en)
|
2005-04-11 |
2010-09-16 |
The Procter & Gamble Company |
Compositions comprising probiotic and sweetener components
|
EP1714660A1
(en)
|
2005-04-21 |
2006-10-25 |
N.V. Nutricia |
Uronic acid and probiotics
|
DK1874917T3
(da)
|
2005-04-26 |
2012-05-14 |
Teagasc Agric Food Dev Authori |
Probiotisk sammensætning, der er egnet til dyr
|
CN101213297B
(zh)
|
2005-05-09 |
2013-02-13 |
小野药品工业株式会社 |
程序性死亡-1(pd-1)的人单克隆抗体及单独使用或与其它免疫治疗剂联合使用抗pd-1抗体来治疗癌症的方法
|
US7572474B2
(en)
|
2005-06-01 |
2009-08-11 |
Mead Johnson Nutrition Company |
Method for simulating the functional attributes of human milk oligosaccharides in formula-fed infants
|
US8075934B2
(en)
|
2008-10-24 |
2011-12-13 |
Mead Johnson Nutrition Company |
Nutritional composition with improved digestibility
|
JP2007084533A
(ja)
|
2005-08-24 |
2007-04-05 |
Prima Meat Packers Ltd |
免疫応答調節組成物及び該組成物を有効成分とする食品
|
US7625704B2
(en)
|
2005-08-31 |
2009-12-01 |
Fred Hutchinson Cancer Research Center |
Methods and compositions for identifying bacteria associated with bacteria vaginosis
|
EP1933869B1
(en)
|
2005-09-01 |
2009-10-14 |
Schering Corporation |
Use of il-23 and il-17 antagonists to treat autoimmune ocular inflammatory disease
|
US20090028840A1
(en)
|
2005-09-23 |
2009-01-29 |
Gwangju Institute Of Sciecne And Technology |
Compositions For Preventing Or Treating Arthritis Comprising Lactic Acid Bacteria and Collangen As Active Ingredients
|
EP1776877A1
(en)
|
2005-10-21 |
2007-04-25 |
N.V. Nutricia |
Method for stimulating the intestinal flora
|
WO2007050656A2
(en)
|
2005-10-24 |
2007-05-03 |
Nestec S.A. |
Dietary fiber formulation and method of administration
|
JP2007116991A
(ja)
|
2005-10-28 |
2007-05-17 |
Eternal Light General Institute Inc |
機能性食品
|
US7767420B2
(en)
|
2005-11-03 |
2010-08-03 |
Momenta Pharmaceuticals, Inc. |
Heparan sulfate glycosaminoglycan lyase and uses thereof
|
US7553864B2
(en)
|
2005-12-01 |
2009-06-30 |
Schering Corporation |
Compounds for the treatment of inflammatory disorders and microbial diseases
|
US8889149B2
(en)
|
2006-02-16 |
2014-11-18 |
Wayne State University |
Use of flagellin to prevent and treat gram negative bacterial infection
|
US20080260906A1
(en)
|
2006-03-17 |
2008-10-23 |
Marko Stojanovic |
Compositions comprising probiotic and sweetener components
|
JP5031249B2
(ja)
|
2006-03-22 |
2012-09-19 |
学校法人北里研究所 |
炎症抑制作用のある菌体含有組成物
|
US20090252708A1
(en)
|
2006-05-18 |
2009-10-08 |
Biobalance Llc |
Biotherapeutic compositions comprising probiotic escherichia coli and uses thereof
|
MY147954A
(en)
|
2006-05-26 |
2013-02-15 |
Nestec Sa |
Methods of use and nutritional compositions of touchi extract
|
CA2654457A1
(en)
|
2006-06-06 |
2007-12-13 |
Mcgill University |
Fermented milk product and use thereof
|
TW200819540A
(en)
|
2006-07-11 |
2008-05-01 |
Genelux Corp |
Methods and compositions for detection of microorganisms and cells and treatment of diseases and disorders
|
AU2007280272A1
(en)
|
2006-08-04 |
2008-02-07 |
Shs International Ltd |
Protein free formula
|
WO2008031438A2
(en)
|
2006-09-13 |
2008-03-20 |
Region Hovedstaden V/Gentofte Hospital |
Treatment of asthma, eczema and/or allergy using non-pathogenic organisms
|
US20080069861A1
(en)
|
2006-09-19 |
2008-03-20 |
National Starch And Chemical Investment Holding Corporation |
Probiotic/Non-Probiotic Combinations
|
ES2895666T3
(es)
|
2006-10-27 |
2022-02-22 |
Capsugel Belgium Nv |
Cápsulas duras de hidroxipropilmetilcelulosa y proceso de fabricación
|
WO2008053444A2
(en)
|
2006-11-01 |
2008-05-08 |
The Procter & Gamble Company |
Treating a respiratory condition with bifidobacterium
|
PL1920781T3
(pl)
|
2006-11-10 |
2015-06-30 |
Glycotope Gmbh |
Kompozycje zawierające core-1-dodatnie mikroorganizmy i ich zastosowanie w leczeniu lub profilaktyce nowotworów
|
WO2008064489A1
(en)
|
2006-12-01 |
2008-06-05 |
Mcmaster University |
Probiotics to inhibit inflammation
|
US20100172874A1
(en)
|
2006-12-18 |
2010-07-08 |
The Washington University |
Gut microbiome as a biomarker and therapeutic target for treating obesity or an obesity related disorder
|
DE102006062250A1
(de)
|
2006-12-22 |
2008-06-26 |
Roland Saur-Brosch |
Verwendung einer Zusammensetzung aus Mineralstoffen und/oder Vitaminen und gegebenenfalls acetogenen und/oder butyrogenen Bakterien zur oralen oder rektalen Verabreichung für die Behandlung und Vorbeugung von abdominalen Beschwerden
|
WO2008083157A2
(en)
|
2006-12-29 |
2008-07-10 |
Washington University In St. Louis |
Altering pgc-1alapha, ampk, fiaf, or the gastrointestinal microbiota as a means to modulate body fat and/or weight loss in a subject
|
JP2008195635A
(ja)
|
2007-02-09 |
2008-08-28 |
Crossfield Bio Inc |
馬用乳酸菌製剤
|
ATE544457T1
(de)
|
2007-02-28 |
2012-02-15 |
Mead Johnson Nutrition Co |
Verfahren zur behandlung bzw. prävention systemischer entzündungen
|
CN101679938B
(zh)
|
2007-03-28 |
2014-03-19 |
营养健康有限公司 |
益生双歧杆菌菌株
|
US8557233B2
(en)
|
2007-03-28 |
2013-10-15 |
Alimentary Heath Limited |
Probiotic bifidobacterium strains
|
EP2147091A4
(en)
|
2007-04-24 |
2010-12-08 |
Kemin Ind Inc |
ANTIBACTERIAL AND ANTIFUNGAL ACTIVITY WITH LACTOBACILLUS JOHNSONII D115 LARGE SPECTRUM
|
EP1997499A1
(en)
|
2007-05-31 |
2008-12-03 |
Puleva Biotech, S.A. |
Mammalian milk microorganisms, compositions containing them and their use for the treatment of mastitis
|
EP1997905A1
(en)
|
2007-06-01 |
2008-12-03 |
Friesland Brands B.V. |
Nucleic acid amplification
|
EP1997906A1
(en)
|
2007-06-01 |
2008-12-03 |
Friesland Brands B.V. |
Lactobacillus
|
EP1997907A1
(en)
|
2007-06-01 |
2008-12-03 |
Friesland Brands B.V. |
Bifidobacteria
|
WO2008153377A1
(en)
|
2007-06-15 |
2008-12-18 |
N.V. Nutricia |
Nutrition with non-viable bifidobacterium and non-digestible oligosaccharide
|
WO2009002145A1
(en)
|
2007-06-26 |
2008-12-31 |
N.V. Nutricia |
Lipid composition for improving function of brain functioning
|
WO2009000899A1
(en)
|
2007-06-27 |
2008-12-31 |
Laboratorios Ordesa, S.L. |
A novel strain of bifidobacterium and active peptides against rotavirus infections
|
HUP0700552A2
(en)
|
2007-08-27 |
2009-03-30 |
Janos Dr Feher |
Method and composition inhibiting inflammation
|
WO2009030254A1
(en)
|
2007-09-04 |
2009-03-12 |
Curevac Gmbh |
Complexes of rna and cationic peptides for transfection and for immunostimulation
|
EP2192909A2
(en)
|
2007-10-01 |
2010-06-09 |
University College Cork-National University of Ireland, Cork |
Modulation of tissue fatty acid composition of a host by human gut bacteria
|
EP2203551B1
(en)
|
2007-10-20 |
2013-08-21 |
Université de Liège |
Bifidobacterial species
|
WO2009055362A1
(en)
|
2007-10-26 |
2009-04-30 |
Moore Brenda E |
Probiotic compositions and methods for inducing and supporting weight loss
|
EP2205642B1
(en)
|
2007-11-02 |
2016-01-27 |
Momenta Pharmaceuticals, Inc. |
Non-anticoagulant polysaccharide compositions
|
EP2065048A1
(en)
|
2007-11-30 |
2009-06-03 |
Institut Pasteur |
Use of a L. casei strain, for the preparation of a composition for inhibiting mast cell activation
|
EP2898889B1
(en)
|
2007-12-07 |
2017-03-22 |
N.V. Nutricia |
Bifidobacterium for dust mite allergy
|
US20100330190A1
(en)
|
2007-12-17 |
2010-12-30 |
Compans Richard W |
Immunogenic compositions and methods of use thereof
|
ES2343499B1
(es)
|
2007-12-24 |
2011-06-10 |
Consejo Superior De Investigaciones Cientificas |
Microorganismos para mejorar el estado de salud de individuos con desordenes relacionados con la ingesta de gluten.
|
CN101939411A
(zh)
|
2008-02-06 |
2011-01-05 |
宝洁公司 |
用于提高呼吸病症免疫应答的组合物、方法和试剂盒
|
EP2103226A1
(en)
|
2008-03-18 |
2009-09-23 |
Friesland Brands B.V. |
Long-life probiotic food product
|
JP2011519828A
(ja)
|
2008-04-18 |
2011-07-14 |
バクシネート コーポレーション |
フラジェリンの欠失変異体と使用方法
|
US8741365B2
(en)
|
2008-05-13 |
2014-06-03 |
Glycotope Gmbh |
Fermentation process
|
MX2008006546A
(es)
|
2008-05-21 |
2009-11-23 |
Sigma Alimentos Sa De Cv |
Bifidobacteria productora de ácido fólico, composición alimenticia y uso de la bifidobacteria.
|
CN102940652B
(zh)
|
2008-05-28 |
2015-03-25 |
青岛东海药业有限公司 |
两形真杆菌制剂及其应用
|
CN101590081A
(zh)
|
2008-05-28 |
2009-12-02 |
青岛东海药业有限公司 |
凸腹真杆菌和两形真杆菌制剂及其应用
|
US8586029B2
(en)
|
2008-06-04 |
2013-11-19 |
Trustees Of Dartmouth College |
Prevention or treatment of immune-relevant disease by modification of microfloral populations
|
CN101596216A
(zh)
*
|
2008-06-06 |
2009-12-09 |
萧湘 |
预防或治疗糖尿病和相关病症的微生物制剂
|
EP2133088A3
(en)
|
2008-06-09 |
2010-01-27 |
Nestec S.A. |
Rooibos and inflammation
|
WO2009151315A1
(en)
|
2008-06-13 |
2009-12-17 |
N.V. Nutricia |
Nutritional composition for infants delivered via caesarean section
|
WO2009154463A2
(en)
|
2008-06-20 |
2009-12-23 |
Stichting Top Institute Food And Nutrition |
Butyrate as a medicament to improve visceral perception in humans
|
EP2138186A1
(en)
|
2008-06-24 |
2009-12-30 |
Nestec S.A. |
Probiotics, secretory IgA and inflammation
|
WO2010002241A1
(en)
|
2008-06-30 |
2010-01-07 |
N.V. Nutricia |
Nutritional composition for infants delivered via caesarean section
|
KR101017448B1
(ko)
|
2008-09-18 |
2011-02-23 |
주식회사한국야쿠르트 |
대장의 건강 증진 효능을 갖는 비피도박테리움 롱검 에이취와이8004 및 이를 유효성분으로 함유하는 제품
|
US20100074870A1
(en)
|
2008-09-19 |
2010-03-25 |
Bristol-Myers Squibb Company |
Probiotic infant products
|
US8137718B2
(en)
|
2008-09-19 |
2012-03-20 |
Mead Johnson Nutrition Company |
Probiotic infant products
|
KR101057357B1
(ko)
|
2008-09-22 |
2011-08-17 |
광주과학기술원 |
유산균 및 콜라겐을 유효성분으로 포함하는 관절염 예방 또는 치료용 약제학적 조성물 및 식품 조성물
|
WO2010036876A2
(en)
|
2008-09-25 |
2010-04-01 |
New York University |
Compositions and methods for characterizing and restoring gastrointestinal, skin, and nasal microbiota
|
WO2010037408A1
(en)
|
2008-09-30 |
2010-04-08 |
Curevac Gmbh |
Composition comprising a complexed (m)rna and a naked mrna for providing or enhancing an immunostimulatory response in a mammal and uses thereof
|
WO2010037402A1
(en)
|
2008-10-02 |
2010-04-08 |
Dako Denmark A/S |
Molecular vaccines for infectious disease
|
WO2010063601A1
(en)
|
2008-12-05 |
2010-06-10 |
Nestec S.A. |
Compositions for use in low-birth weight infants
|
BRPI0923171A2
(pt)
|
2008-12-19 |
2015-08-11 |
Nestec Sa |
Prevenção e tratamento da diarréia causada por rotavírus.
|
IT1392672B1
(it)
|
2009-01-12 |
2012-03-16 |
Wyeth Consumer Healthcare S P A |
Composizioni comprendenti componenti probiotici e prebiotici e sali minerali, con lactoferrina
|
RU2015132478A
(ru)
|
2009-03-05 |
2015-12-10 |
Эббви Инк. |
Связывающие il-17 белки
|
JP5710876B2
(ja)
|
2009-03-26 |
2015-04-30 |
クロスフィールドバイオ株式会社 |
新規ビフィドバクテリウム属微生物およびその利用
|
JP6077303B2
(ja)
|
2009-05-07 |
2017-02-08 |
タト エ リル アングルディアント フランス ソシエテ パ アクシオンス シンプリフィエ |
アルファ−(1,2)−分岐アルファ−(1,6)オリゴデキストランを含有する組成物及びアルファ−(1,2)−分岐アルファ−(1,6)オリゴデキストランの製造方法
|
EP2251022A1
(en)
|
2009-05-11 |
2010-11-17 |
Nestec S.A. |
Non-replicating micro-organisms and their immune boosting effect
|
EP2251020A1
(en)
|
2009-05-11 |
2010-11-17 |
Nestec S.A. |
Short-time high temperature treatment generates microbial preparations with anti-inflammatory profiles
|
JP2012526752A
(ja)
|
2009-05-11 |
2012-11-01 |
ネステク ソシエテ アノニム |
ビフィドバクテリウム・ロンガムncc2705(cncmi−2618)及び免疫障害
|
KR20100128168A
(ko)
|
2009-05-27 |
2010-12-07 |
중앙대학교 산학협력단 |
공액 리놀레산 생산능이 우수한 신규한 균주
|
US20100311686A1
(en)
|
2009-06-03 |
2010-12-09 |
Kasper Lloyd H |
Nutraceutical composition and methods for preventing or treating multiple sclerosis
|
WO2010143940A1
(en)
|
2009-06-12 |
2010-12-16 |
N.V. Nutricia |
Synergistic mixture of beta-galacto-oligosaccharides with beta-1,3 and beta-1,4/1,6 linkages
|
WO2010147714A1
(en)
|
2009-06-16 |
2010-12-23 |
The Trustees Of Columbia University In The City Of New York |
Autism-associated biomarkers and uses thereof
|
US9050276B2
(en)
*
|
2009-06-16 |
2015-06-09 |
The Trustees Of Columbia University In The City Of New York |
Autism-associated biomarkers and uses thereof
|
WO2011005756A1
(en)
|
2009-07-06 |
2011-01-13 |
Puretech Ventures, Llc |
Delivery of agents targeted to microbiota niches
|
EP2456891A4
(en)
|
2009-07-24 |
2013-04-03 |
Southwest Regional Pcr Llc |
DIAGNOSIS, DETECTION, QUANTIFICATION UNIVERSAL MICROBIENS, AND TARGETED THERAPY ON A SAMPLE
|
SG178167A1
(en)
|
2009-08-18 |
2012-03-29 |
Nestec Sa |
A nutritional composition comprising bifidobacterium longum strains and reducing food allergy symptoms, especially in infants and children
|
US20110053829A1
(en)
|
2009-09-03 |
2011-03-03 |
Curevac Gmbh |
Disulfide-linked polyethyleneglycol/peptide conjugates for the transfection of nucleic acids
|
GB2473294B
(en)
|
2009-09-08 |
2014-07-09 |
Mclaren Automotive Ltd |
Dynamics control
|
PL2480255T3
(pl)
|
2009-09-23 |
2018-07-31 |
Thomas Julius Borody |
Terapia przewlekłych zakażeń jelitowych
|
EP2308498A1
(en)
|
2009-09-30 |
2011-04-13 |
Nestec S.A. |
Administration of Bifidobacterium breve during infancy to prevent inflammation later in life
|
US20120238468A1
(en)
|
2009-10-05 |
2012-09-20 |
Aak Patent B.V. |
Methods for diagnosing irritable bowel syndrome
|
WO2011044208A1
(en)
|
2009-10-06 |
2011-04-14 |
Scott Dorfner |
Antibiotic formulations providing reduced gastrointentestinal side effects
|
CA2779418C
(en)
|
2009-11-11 |
2018-03-20 |
Alimentary Health Limited |
Probiotic bifidobacterium strain
|
MY162183A
(en)
|
2009-12-01 |
2017-05-31 |
Univ Putra Malaysia |
Probiotic composition for nutraceutical product
|
RU2533024C2
(ru)
|
2009-12-18 |
2014-11-20 |
Хилл`С Пет Ньютришн, Инк. |
Композиции кормовых продуктов для домашних животных, включающие пробиотики, способы их получения и применение
|
JP5557520B2
(ja)
|
2009-12-22 |
2014-07-23 |
京楽産業.株式会社 |
遊技機の演出用動力伝達機構及びこれを備える遊技機
|
US20150104418A1
(en)
|
2014-12-18 |
2015-04-16 |
Microbios, Inc. |
Bacterial composition
|
FR2955774A1
(fr)
|
2010-02-02 |
2011-08-05 |
Aragan |
Preparation destinee a traiter l'exces ponderal et les desordres associes et applications de ladite preparation
|
NL2004200C2
(en)
|
2010-02-05 |
2011-08-08 |
Friesland Brands Bv |
Use of sialyl oligosaccharides in weight management.
|
NL2004201C2
(en)
|
2010-02-05 |
2011-08-08 |
Friesland Brands Bv |
Use of sialyl oligosaccharides to modulate the immune system.
|
IT1398553B1
(it)
|
2010-03-08 |
2013-03-01 |
Probiotical Spa |
Composizione comprendente batteri probiotici per il trattamento di patologie associate con le alterazioni del sistema immunitario.
|
JP5737646B2
(ja)
|
2010-03-24 |
2015-06-17 |
森下仁丹株式会社 |
抗アレルギー剤
|
WO2011121379A1
(en)
|
2010-03-30 |
2011-10-06 |
Assistance Publique - Hopitaux De Paris |
Use of bifidobacteria for preventing allergy in breastfed infants
|
US8951512B2
(en)
|
2010-05-04 |
2015-02-10 |
New York University |
Methods for treating bone disorders by characterizing and restoring mammalian bacterial microbiota
|
WO2011149335A1
(en)
|
2010-05-25 |
2011-12-01 |
N.V. Nutricia |
Immune imprinting nutritional composition
|
KR20130086155A
(ko)
|
2010-06-01 |
2013-07-31 |
무어 리서치 엔터프라이지스 엘엘씨 |
박테로이데스로부터의 세포 성분, 그의 조성물, 및 박테로이데스 또는 그의 세포 성분을 이용하는 치료 방법
|
WO2011151941A1
(ja)
|
2010-06-04 |
2011-12-08 |
国立大学法人東京大学 |
制御性t細胞の増殖または集積を誘導する作用を有する組成物
|
TWI417054B
(zh)
|
2010-06-15 |
2013-12-01 |
Jen Shine Biotechnology Co Ltd |
新穎糞腸球菌ljs-01及其益生用途
|
EP2397145A1
(en)
|
2010-06-18 |
2011-12-21 |
Nestec S.A. |
L. johnsonii La1, B. longum NCC2705 and immune disorders
|
FR2962045B1
(fr)
|
2010-07-05 |
2012-08-17 |
Bifinove |
Complexe macromoleculaire d'origine bacterienne et utilisation dudit complexe moleculaire pour prevenir et traiter les rhumatismes inflammatoires
|
CN101914452B
(zh)
*
|
2010-07-14 |
2011-12-07 |
洪亚辉 |
石杉碱甲高产菌株tcm-01
|
TWI401086B
(zh)
|
2010-07-20 |
2013-07-11 |
Univ China Medical |
胚芽乳酸桿菌及其用途
|
KR102157718B1
(ko)
|
2010-07-26 |
2020-09-18 |
큐 바이올로직스 인코포레이티드 |
면역원성 소염 조성물
|
AU2011286165B2
(en)
|
2010-08-04 |
2016-10-20 |
Thomas Julius Borody |
Compositions for fecal floral transplantation and methods for making and using them and devices for delivering them
|
WO2012024638A2
(en)
|
2010-08-20 |
2012-02-23 |
New York University |
Compositions and methods for treating obesity and related disorders by characterizing and restoring mammalian bacterial microbiota
|
KR101250463B1
(ko)
|
2010-10-12 |
2013-04-15 |
대한민국 |
신생아 분변에서 분리한 내산소성 비피도박테리움 롱검 비피더스 유산균 및 이를 이용한 프로바이오틱 조성물
|
WO2012055408A1
(en)
|
2010-10-27 |
2012-05-03 |
Quantibact A/S |
Capture of target dna and rna by probes comprising intercalator molecules
|
CN102031235B
(zh)
|
2010-11-09 |
2012-07-25 |
中国农业大学 |
一种粪肠球菌anse228及其应用
|
EP2455092A1
(en)
|
2010-11-11 |
2012-05-23 |
Nestec S.A. |
Non-replicating probiotic micro-organisms protect against upper respiratory tract infections
|
US20120128644A1
(en)
|
2010-11-24 |
2012-05-24 |
Oragenics, Inc. |
Use of Bacteria to Treat and Prevent Respiratory Infections
|
CN102093967B
(zh)
|
2010-12-02 |
2013-01-30 |
中国农业科学院特产研究所 |
一株水貂源屎肠球菌及其应用
|
ES2389547B1
(es)
|
2010-12-07 |
2013-08-08 |
Consejo Superior De Investigaciones Científicas (Csic) |
Bifidobacterium cect 7765 y su uso en la prevención y/o tratamiento del sobrepeso, la obesidad y patologías asociadas.
|
AU2012205681B2
(en)
|
2011-01-10 |
2016-07-28 |
Cleveland Biolabs, Inc. |
Use of toll-like receptor agonist for treating cancer
|
PT2481299T
(pt)
|
2011-01-31 |
2017-03-08 |
Synformulas Gmbh |
Estirpes de bifidobacterium bifidum para aplicação em doenças gastrointestinais
|
JP5840368B2
(ja)
|
2011-02-02 |
2016-01-06 |
カルピス株式会社 |
関節炎予防改善用物質
|
PL2672980T3
(pl)
|
2011-02-09 |
2018-05-30 |
Lavivo Ab |
Synbiotyczne kompozycje dla odnowienia i odtworzenia flory bakteryjnej jelita
|
EP3610881A1
(en)
|
2011-03-09 |
2020-02-19 |
Regents Of The University Of Minnesota |
Compositions and methods for transplantation of colon microbiota
|
BRPI1100857A2
(pt)
|
2011-03-18 |
2013-05-21 |
Alexandre Eduardo Nowill |
agente imunomodulador e suas combinaÇÕes, seu uso e mÉtodo imunoterÁpico para a recontextualizaÇço, reprogramaÇço e reconduÇço do sistema imune em tempo real
|
WO2012140636A1
(en)
|
2011-04-11 |
2012-10-18 |
Alimentary Health Limited |
A probiotic formulation
|
WO2012142605A1
(en)
|
2011-04-15 |
2012-10-18 |
Samaritan Health Services |
Rapid recolonization deployment agent
|
EA201391553A1
(ru)
|
2011-04-20 |
2014-03-31 |
Майко Байо, Инк. |
Композиция и способ усиления иммунного ответа
|
US9567361B2
(en)
|
2011-05-13 |
2017-02-14 |
Glycosyn LLC |
Use of purified 2′-fucosyllactose, 3-fucosyllactose and lactodifucotetraose as prebiotics
|
KR20120133133A
(ko)
|
2011-05-30 |
2012-12-10 |
한국 한의학 연구원 |
생약 추출물 또는 이의 유산균 발효물을 포함하는 호흡기 질환의 예방 또는 치료용 조성물
|
US20140171339A1
(en)
|
2011-06-06 |
2014-06-19 |
The University Of North Carolina At Chapel Hill |
Methods and kits for detecting adenomas, colorectal cancer, and uses thereof
|
GB201110095D0
(en)
|
2011-06-15 |
2011-07-27 |
Danisco |
Method of treatment
|
US9579353B2
(en)
*
|
2011-06-10 |
2017-02-28 |
Prothera, Inc. |
Pharmaceutical compositions containing pediococcus and methods for reducing the symptoms of gastroenterological syndromes
|
JP2013005759A
(ja)
|
2011-06-24 |
2013-01-10 |
Kyodo Milk Industry Co Ltd |
マウス腸内菌叢の推測方法
|
CN102408998B
(zh)
*
|
2011-06-28 |
2013-06-05 |
深圳大学 |
一种具有神经退行性疾病防治活性的海洋红树耐盐性内生真菌
|
US20140128585A1
(en)
|
2011-07-07 |
2014-05-08 |
Nagaoka Perfumery Co., Ltd. |
Fructose absorption inhibitor
|
GB201112091D0
(en)
|
2011-07-14 |
2011-08-31 |
Gt Biolog Ltd |
Bacterial strains isolated from pigs
|
WO2013008102A2
(en)
|
2011-07-14 |
2013-01-17 |
R.E.D. Laboratories N.V../ S.A. |
Methods and compositions for evaluating and/or treating chronic immune diseases
|
US20130022575A1
(en)
|
2011-07-19 |
2013-01-24 |
Microbial Rx |
Systems and methods of replacing intestinal flora
|
CN102304483A
(zh)
|
2011-08-12 |
2012-01-04 |
北京金泰得生物科技股份有限公司 |
一株饲用屎肠球菌及其应用
|
KR101261872B1
(ko)
|
2011-08-23 |
2013-05-14 |
대한민국 (식품의약품안전처장) |
장내 미생물 효소복합체 및 이의 제조방법
|
CA2848762C
(en)
|
2011-09-14 |
2021-07-27 |
Queen's University At Kingston |
Method for treatment of disorders of the gastrointestinal system
|
GB201117313D0
(en)
|
2011-10-07 |
2011-11-16 |
Gt Biolog Ltd |
Bacterium for use in medicine
|
EA201490512A1
(ru)
|
2011-10-11 |
2014-09-30 |
Ачим Байотерапьютикс Аб |
Композиции, содержащие культивируемую в анаэробных условиях микробиоту кишечника человека
|
FI126711B
(fi)
|
2011-10-12 |
2017-04-13 |
Gut Guide Oy |
Serotoniinivajeeseen liittyvän terveysriskin arvioiminen
|
CN103082292B
(zh)
|
2011-11-02 |
2015-03-04 |
深圳华大基因研究院 |
罗斯氏菌(Roseburia)在治疗和预防肥胖相关疾病中的应用
|
CN102373172B
(zh)
|
2011-11-03 |
2013-03-20 |
北京龙科方舟生物工程技术有限公司 |
一株屎肠球菌及其应用
|
CA2892588A1
(en)
|
2011-12-01 |
2013-06-06 |
School Corporation, Azabu Veterinary Medicine Educational Institution |
Human-derived bacteria that induce proliferation or accumulation of regulatory t cells
|
ES2408279B1
(es)
|
2011-12-15 |
2014-09-09 |
Universidad De Las Palmas De Gran Canaria |
Bacteria acido láctica probiótica
|
ITBG20120010A1
(it)
|
2012-02-24 |
2013-08-25 |
Milano Politecnico |
Dispositivo per l'addestramento chirurgico
|
ITMI20120471A1
(it)
|
2012-03-26 |
2013-09-27 |
Giovanni Mogna |
Composizione a base di ceppi di batteri bifidobacterium longum in grado di aiutare il prolungamento della vita
|
JP5792105B2
(ja)
|
2012-03-27 |
2015-10-07 |
森永乳業株式会社 |
ラクト−n−ビオースiの製造方法
|
EP2832859B1
(en)
|
2012-03-30 |
2018-07-25 |
Ajinomoto Co., Inc. |
Diabetes-inducible bacterium
|
WO2013154826A2
(en)
|
2012-04-11 |
2013-10-17 |
Nestec Sa |
Methods for diagnosing impending diarrhea
|
GB201206599D0
(en)
|
2012-04-13 |
2012-05-30 |
Univ Manchester |
Probiotic bacteria
|
EP2836218A4
(en)
|
2012-04-13 |
2015-10-21 |
Trustees Boston College |
PROBIOTIC COMPOSITIONS AND METHODS OF USE
|
WO2013171515A1
(en)
|
2012-05-18 |
2013-11-21 |
Genome Research Limited |
Methods and groups
|
ES2436251B1
(es)
|
2012-05-25 |
2014-10-08 |
Consejo Superior De Investigaciones Científicas (Csic) |
Bacteroides cect 7771 y su uso en la prevención y tratamiento de sobrepeso, obesidad y alteraciones metabólicas e inmunológicas.
|
NZ703394A
(en)
|
2012-06-04 |
2017-01-27 |
Centre For Digestive Diseases |
Compositions and methods for treating crohn’s disease and related conditions and infections
|
CN106620189B
(zh)
|
2012-06-06 |
2021-11-19 |
上海交通大学 |
改善肠道菌群结构的方法及应用
|
EP2864355B1
(en)
|
2012-06-25 |
2016-10-12 |
Orega Biotech |
Il-17 antagonist antibodies
|
CA2877811C
(en)
|
2012-07-31 |
2019-07-23 |
Nestec S.A. |
Nutritional composition for promoting musculoskeletal health in patients with inflammatory bowel disease (ibd)
|
WO2014019271A1
(en)
|
2012-08-01 |
2014-02-06 |
Bgi Shenzhen |
Biomarkers for diabetes and usages thereof
|
KR101426276B1
(ko)
*
|
2012-08-16 |
2014-08-05 |
주식회사한국야쿠르트 |
심장질환 및 뇌졸중을 유발하는 거품세포 형성 억제 및 혈관 병변 형성을 억제하는 활성을 가지는 락토바실러스 플란타룸 hy7712를 유효성분으로 함유하는 제품
|
US10874701B2
(en)
|
2012-08-16 |
2020-12-29 |
University-Industry Cooperation Group Of Kyung Hee University |
Lactic acid bacteria capable of preventing and/or treating senescence and dementia
|
EP2890808A4
(en)
|
2012-08-29 |
2016-09-28 |
California Inst Of Techn |
DIAGNOSIS AND TREATMENT OF AUTISTICAL DISEASES
|
KR20150046310A
(ko)
|
2012-08-29 |
2015-04-29 |
샐릭스 파마슈티컬스 인코포레이티드 |
완화제 조성물 및 변비 및 관련 위장관 질병 및 증상 치료를 위한 방법
|
WO2014043593A2
(en)
|
2012-09-13 |
2014-03-20 |
Massachusetts Institute Of Technology |
Programmable drug delivery profiles of tumor-targeted bacteria
|
KR101473058B1
(ko)
|
2012-09-19 |
2014-12-16 |
주식회사 쎌바이오텍 |
과민성 대장 증후군 예방 또는 치료용 조성물
|
CN103652322B
(zh)
|
2012-09-21 |
2016-02-10 |
临沂思科生物科技有限公司 |
一种含乳酸菌的复合益生菌饲料添加剂的制备方法
|
EP2904096A1
(en)
|
2012-10-03 |
2015-08-12 |
Metabogen AB |
Identification of a person having risk for atherosclerosis and associated diseases by the person's gut microbiome and the prevention of such diseases
|
FR2997091B1
(fr)
|
2012-10-22 |
2016-05-06 |
Fond Mediterranee Infection |
Utilisation d'un compose antioxydant pour la culture de bacteries sensibles a la tension en oxygene
|
US9839657B2
(en)
|
2012-10-30 |
2017-12-12 |
Deerland Enzymes, Inc. |
Prebiotic compositions comprising one or more types of bacteriophage
|
WO2014067976A1
(en)
|
2012-10-30 |
2014-05-08 |
Nestec S.A. |
Compositions comprising microparticles and probiotics to deliver a synergistic immune effect
|
EP3345606A1
(en)
|
2012-11-01 |
2018-07-11 |
Rijksuniversiteit Groningen |
Methods and compositions for stimulating beneficial bacteria in the gastrointestinal tract
|
WO2014075745A1
(en)
|
2012-11-19 |
2014-05-22 |
Université Catholique de Louvain |
Use of akkermansia for treating metabolic disorders
|
US8906668B2
(en)
|
2012-11-23 |
2014-12-09 |
Seres Health, Inc. |
Synergistic bacterial compositions and methods of production and use thereof
|
SG10201704035TA
(en)
|
2012-11-23 |
2017-06-29 |
Seres Therapeutics Inc |
Synergistic bacterial compositions and methods of production and use thereof
|
US20150297642A1
(en)
|
2012-11-26 |
2015-10-22 |
Thomas Julius Borody |
Compositions for the restoration of a fecal microbiota and methods for making and using them
|
US8993233B2
(en)
|
2012-12-12 |
2015-03-31 |
The Broad Institute Inc. |
Engineering and optimization of systems, methods and compositions for sequence manipulation with functional domains
|
MX2015007550A
(es)
|
2012-12-12 |
2017-02-02 |
Broad Inst Inc |
Suministro, modificación y optimización de sistemas, métodos y composiciones para la manipulación de secuencias y aplicaciones terapéuticas.
|
PT2898075E
(pt)
|
2012-12-12 |
2016-06-16 |
Harvard College |
Manipulação e otimização de sistemas, métodos e composições de enzima melhorados para manipulação de sequências
|
US20140193464A1
(en)
|
2013-01-08 |
2014-07-10 |
Imagilin Technology, Llc |
Effects of probiotics on humans and animals under environmental or biological changes
|
EP2951283A4
(en)
|
2013-02-04 |
2017-01-25 |
Seres Therapeutics, Inc. |
Compositions and methods
|
KR102222273B1
(ko)
|
2013-02-04 |
2021-03-08 |
세레스 테라퓨틱스, 인코포레이티드 |
조성물 및 방법
|
EP2958575B1
(en)
|
2013-02-22 |
2019-04-03 |
The Regents of The University of California |
Composition comprising lactobaccilus johnsonii 456 and its use in treating or preventing diseases
|
BR112015020819A2
(pt)
|
2013-03-05 |
2017-07-18 |
Academisch Ziekenhuis Groningen |
uso de faecalibacterium prausnitzii htf-f (dsm 26943) para supressão de inflamação
|
RU2015140610A
(ru)
|
2013-03-14 |
2017-04-17 |
ТЕРАБАЙОМ, ЭлЭлСи |
Направленная доставка в желудочно-кишечный тракт пробиотических микроорганизмов и/или терапевтических средств
|
US20160040215A1
(en)
|
2013-03-14 |
2016-02-11 |
Seres Therapeutics, Inc. |
Methods for Pathogen Detection and Enrichment from Materials and Compositions
|
WO2014150094A1
(en)
|
2013-03-15 |
2014-09-25 |
University Of Florida Research Foundation, Inc. |
Butyrogenic bacteria as probiotics to treat clostridium difficile
|
WO2014150139A1
(en)
|
2013-03-15 |
2014-09-25 |
Microbiome Therapeutics, Llc. |
Activated soy pod fiber
|
AU2014232370B2
(en)
|
2013-03-15 |
2018-11-01 |
Seres Therapeutics, Inc. |
Network-based microbial compositions and methods
|
CN103156888A
(zh)
|
2013-03-18 |
2013-06-19 |
广州知光生物科技有限公司 |
脆弱拟杆菌在制备治疗炎症性肠病组合物中的应用
|
CN103142656A
(zh)
|
2013-03-18 |
2013-06-12 |
广州知光生物科技有限公司 |
脆弱拟杆菌在制备防治结肠癌组合物中的应用
|
CN103146620A
(zh)
|
2013-03-25 |
2013-06-12 |
广州知光生物科技有限公司 |
具有益生菌特性的脆弱拟杆菌
|
JP2014196260A
(ja)
|
2013-03-29 |
2014-10-16 |
公立大学法人奈良県立医科大学 |
慢性閉塞性肺疾患の予防又は治療用組成物
|
GB201306536D0
(en)
|
2013-04-10 |
2013-05-22 |
Gt Biolog Ltd |
Polypeptide and immune modulation
|
EP2994161B1
(en)
|
2013-05-10 |
2020-10-28 |
California Institute of Technology |
Probiotic prevention and treatment of colon cancer
|
US10284649B2
(en)
|
2013-05-31 |
2019-05-07 |
Nec Corporation |
Distributed processing system
|
KR102093537B1
(ko)
|
2013-06-05 |
2020-04-23 |
리바이오틱스, 인코퍼레이티드 |
미생물상 복원 요법(mrt), 조성물 및 제조방법
|
US9511099B2
(en)
|
2013-06-05 |
2016-12-06 |
Rebiotix, Inc. |
Microbiota restoration therapy (MRT), compositions and methods of manufacture
|
US20160120915A1
(en)
|
2013-06-10 |
2016-05-05 |
New York University |
Methods for manipulating immune responses by altering microbiota
|
WO2014200334A1
(en)
|
2013-06-14 |
2014-12-18 |
N.V. Nutricia |
Synbiotic composition for treatment of infections in allergic patients
|
WO2015003001A1
(en)
|
2013-07-01 |
2015-01-08 |
The Washington University |
Methods for identifying supplements that increase gut colonization by an isolated bacterial species, and compositions derived therefrom
|
WO2015003305A1
(zh)
|
2013-07-08 |
2015-01-15 |
吉瑞高新科技股份有限公司 |
电子烟盒
|
JP2016530239A
(ja)
|
2013-07-09 |
2016-09-29 |
ピュアテック ベンチャーズ、エルエルシー |
微生物叢由来生物活性分子の組み合わせを含む疾患治療用組成物
|
US10633714B2
(en)
|
2013-07-21 |
2020-04-28 |
Pendulum Therapeutics, Inc. |
Methods and systems for microbiome characterization, monitoring and treatment
|
US20160192689A1
(en)
|
2013-07-31 |
2016-07-07 |
Wikifoods, Inc. |
Encapsulated functional food compositions
|
CN105658226B
(zh)
|
2013-08-16 |
2019-05-14 |
港大科桥有限公司 |
使用益生菌治疗癌症的方法和组合物
|
CN103509741B
(zh)
|
2013-08-22 |
2015-02-18 |
河北农业大学 |
布劳特菌auh-jld56及其在牛蒡苷元转化中的应用
|
CN104415060A
(zh)
|
2013-08-30 |
2015-03-18 |
深圳华大基因科技有限公司 |
可食用组合物及其制备方法和用途
|
ITMI20131467A1
(it)
|
2013-09-06 |
2015-03-07 |
Sofar Spa |
Uso di una composizione comprendente microrganismi per aumentare la produzione intestinale di acido butirrico, di acido folico o di niacina e/o per diminuire la produzione intestinale di acido succinico
|
US10203329B2
(en)
|
2013-09-12 |
2019-02-12 |
The Johns Hopkins University |
Biofilm formation to define risk for colon cancer
|
US10058576B2
(en)
|
2013-10-03 |
2018-08-28 |
The Trustees Of The University Of Pennsylvania |
Compositions and methods comprising a defined microbiome and methods of use thereof
|
US10292413B2
(en)
|
2013-10-18 |
2019-05-21 |
Innovachildfood Ab |
Nutritionally balanced composite meal for infants and small children and a method of producing said meal
|
PL229020B1
(pl)
|
2013-11-13 |
2018-05-30 |
Inst Biotechnologii Surowic I Szczepionek Biomed Spolka Akcyjna |
Nowy szczep Bifidobacterium breve
|
KR102379658B1
(ko)
|
2013-11-25 |
2022-03-28 |
세레스 테라퓨틱스, 인코포레이티드 |
상승적 박테리아 조성물 및 그것의 생산 방법 및 용도
|
US9956282B2
(en)
|
2013-12-16 |
2018-05-01 |
Seres Therapeutics, Inc. |
Bacterial compositions and methods of use thereof for treatment of immune system disorders
|
CN103981115B
(zh)
|
2013-12-24 |
2018-10-26 |
北京大伟嘉生物技术股份有限公司 |
一株高抗逆性屎肠球菌及其应用
|
CN103981117B
(zh)
|
2013-12-24 |
2018-10-26 |
北京大伟嘉生物技术股份有限公司 |
一株高抗逆性屎肠球菌及其培养方法和应用
|
CN103820363B
(zh)
|
2014-01-27 |
2016-02-24 |
福建省农业科学院生物技术研究所 |
一种屎肠球菌菌粉的制备与应用
|
CN103865846B
(zh)
|
2014-02-27 |
2016-03-30 |
扬州绿保生物科技有限公司 |
一种屎肠球菌及其制备方法
|
CN103849590B
(zh)
|
2014-03-25 |
2016-07-06 |
上海交通大学 |
一株耐酸短双歧杆菌BB8dpH及其应用
|
KR101683474B1
(ko)
|
2014-03-26 |
2016-12-08 |
주식회사 쎌바이오텍 |
과민성 대장 증후군 예방 또는 치료용 조성물
|
US9783858B2
(en)
|
2014-04-02 |
2017-10-10 |
Northwestern University |
Altered microbiome of chronic pelvic pain
|
KR101583546B1
(ko)
|
2014-04-09 |
2016-01-11 |
국립암센터 |
유전자 다형성을 이용한 소라페닙 치료에 대한 반응성 예측방법
|
WO2015156419A1
(en)
|
2014-04-10 |
2015-10-15 |
Riken |
Compositions and methods for induction of th17 cells
|
CN104195075B
(zh)
|
2014-08-14 |
2017-04-19 |
生合生物科技股份有限公司 |
一种屎肠球菌ef08及包含它的饲料添加物和饲料
|
WO2015168534A1
(en)
|
2014-05-02 |
2015-11-05 |
Novogy, Inc. |
Therapeutic treatment of gastrointestinal microbial imbalances through competitive microbe displacement
|
AU2015257651B2
(en)
|
2014-05-08 |
2020-01-23 |
Panoptes Pharma Ges.M.B.H. |
Compounds for treating ophthalmic diseases and disorders
|
CN106573044B
(zh)
|
2014-08-05 |
2020-01-21 |
深圳华大基因科技有限公司 |
真杆菌属在预防和治疗结直肠癌相关疾病中的用途
|
CN106687130B
(zh)
|
2014-08-05 |
2020-01-21 |
深圳华大基因科技有限公司 |
真杆菌属在预防和治疗结直肠癌相关疾病中的用途
|
WO2016033439A2
(en)
|
2014-08-28 |
2016-03-03 |
Yale University |
Compositions and methods for the treating an inflammatory disease or disorder
|
WO2016036615A1
(en)
|
2014-09-03 |
2016-03-10 |
California Institute Of Technology |
Microbe-based modulation of serotonin biosynthesis
|
CN104546942A
(zh)
|
2014-09-30 |
2015-04-29 |
深圳华大基因科技有限公司 |
多氏拟杆菌在治疗或预防类风湿性关节炎或其相关疾病中的应用
|
CN104546932A
(zh)
|
2014-09-30 |
2015-04-29 |
深圳华大基因科技有限公司 |
卵形拟杆菌在治疗或预防类风湿性关节炎或其相关疾病中的应用
|
CN104546935A
(zh)
|
2014-09-30 |
2015-04-29 |
深圳华大基因科技有限公司 |
多形拟杆菌在治疗或预防类风湿性关节炎或其相关疾病中的应用
|
CN104546933A
(zh)
|
2014-09-30 |
2015-04-29 |
深圳华大基因科技有限公司 |
粪拟杆菌在治疗或预防类风湿性关节炎或其相关疾病中的应用
|
CN104546940A
(zh)
|
2014-09-30 |
2015-04-29 |
深圳华大基因科技有限公司 |
平常拟杆菌在治疗或预防类风湿性关节炎或其相关疾病中的应用
|
CN104546934B
(zh)
|
2014-09-30 |
2019-04-09 |
深圳华大基因科技有限公司 |
粪副拟杆菌在治疗或预防类风湿性关节炎或其相关疾病中的应用
|
US10046030B2
(en)
|
2014-10-07 |
2018-08-14 |
University Of Virginia Patent Foundation |
Compositions and methods for preventing and treating infection
|
DK3209308T3
(da)
|
2014-10-24 |
2022-10-03 |
Evolve Biosystems Inc |
Aktiverede bifidobakterier og fremgangsmåder til anvendelse deraf
|
AU2015339290B8
(en)
|
2014-10-30 |
2021-08-26 |
California Institute Of Technology |
Compositions and methods comprising bacteria for improving behavior in neurodevelopmental disorders
|
EP3212207A4
(en)
|
2014-10-30 |
2018-06-13 |
California Institute of Technology |
Compositions and methods comprising bacteria for improving behavior in neurodevelopmental disorders
|
CA2964480A1
(en)
|
2014-10-31 |
2016-05-06 |
Whole Biome Inc. |
Methods and compositions relating to microbial treatment and diagnosis of disorders
|
CN104435000A
(zh)
|
2014-11-12 |
2015-03-25 |
江南大学 |
乳酸菌对支气管哮喘治疗中的应用
|
CN107249609A
(zh)
|
2014-11-25 |
2017-10-13 |
纪念斯隆-凯特琳癌症中心 |
肠道微生物群和gvhd
|
MA41020A
(fr)
|
2014-11-25 |
2017-10-03 |
Evelo Biosciences Inc |
Compositions probiotiques et prébiotiques, et leurs procédés d'utilisation pour la modulation du microbiome
|
HUE037476T2
(hu)
|
2014-12-23 |
2018-08-28 |
4D Pharma Res Ltd |
Pirin polipeptid és immunmodulálás
|
EP3065748B1
(en)
|
2014-12-23 |
2017-11-22 |
4D Pharma Research Limited |
A bacteroides thetaiotaomicron strain and its use in reducing inflammation
|
CN104560820B
(zh)
|
2014-12-30 |
2017-10-20 |
杭州师范大学 |
屎肠球菌kq2.6及应用
|
US20160199425A1
(en)
*
|
2015-01-08 |
2016-07-14 |
Nubiome, Inc. |
Treatment and Prophylaxis for Parkinson's Disease
|
KR20170128247A
(ko)
|
2015-01-23 |
2017-11-22 |
템플 유니버시티-오브 더 커먼웰쓰 시스템 오브 하이어 에듀케이션 |
암 예방에서 단쇄 지방산의 용도
|
CN105982919A
(zh)
|
2015-02-26 |
2016-10-05 |
王汉成 |
生物减速剂抗癌技术
|
WO2016139217A1
(en)
|
2015-03-04 |
2016-09-09 |
Ab-Biotics, S.A. |
Composition comprising anaerobically cultivated human intestinal microbiota
|
CA2976956A1
(en)
|
2015-03-18 |
2016-09-22 |
Whole Biome Inc. |
Methods and compositions relating to microbial treatment and diagnosis of skin disorders
|
US20180078587A1
(en)
|
2015-03-18 |
2018-03-22 |
Trustees Of Tufts College |
Compositions and methods for preventing colorectal cancer
|
KR20160131237A
(ko)
*
|
2015-05-06 |
2016-11-16 |
한양대학교 산학협력단 |
C5-c8 유기산을 생산하는 신규 균주 및 이를 이용하여 c5-c8 유기산을 생산하는 방법
|
KR101745084B1
(ko)
|
2015-05-06 |
2017-06-09 |
한양대학교 산학협력단 |
메가스페라 헥사노이카 균주를 이용하여 헥사노익산을 생산하는 방법
|
CA2987129A1
(en)
|
2015-06-01 |
2016-12-08 |
The University Of Chicago |
Treatment of cancer by manipulation of commensal microflora
|
MA41060B1
(fr)
*
|
2015-06-15 |
2019-11-29 |
4D Pharma Res Ltd |
Compositions comprenant des souches bactériennes
|
EP3307288B1
(en)
|
2015-06-15 |
2019-07-24 |
4D Pharma Research Limited |
Compositions comprising bacterial strains
|
RS63089B1
(sr)
|
2015-06-15 |
2022-04-29 |
4D Pharma Res Ltd |
Kompozicije koje sadrže bakterijske sojeve
|
MA41010B1
(fr)
|
2015-06-15 |
2020-01-31 |
4D Pharma Res Ltd |
Compositions comprenant des souches bactériennes
|
PL3240554T3
(pl)
|
2015-06-15 |
2020-02-28 |
4D Pharma Research Limited |
Blautia stercosis i wexlerae do stosowania w leczeniu chorób zapalnych i autoimmunologicznych
|
US11771065B2
(en)
|
2015-08-20 |
2023-10-03 |
Api Holdings, Llc |
Formulations and methods for promoting honeybee health
|
CN105112333A
(zh)
|
2015-08-31 |
2015-12-02 |
江南大学 |
一种具有良好肠道定殖能力的长双歧杆菌及筛选方法和应用
|
CA3003908A1
(en)
|
2015-11-03 |
2017-05-11 |
The Brigham And Women's Hospital, Inc. |
Therapeutic microbiota for the treatment and/or prevention of food allergy
|
MA41013B1
(fr)
|
2015-11-20 |
2018-07-31 |
4D Pharma Res Ltd |
Compositions comprenant des souches bactériennes
|
GB201520497D0
(en)
|
2015-11-20 |
2016-01-06 |
4D Pharma Res Ltd |
Compositions comprising bacterial strains
|
GB201520638D0
(en)
|
2015-11-23 |
2016-01-06 |
4D Pharma Res Ltd |
Compositions comprising bacterial strains
|
GB201520631D0
(en)
|
2015-11-23 |
2016-01-06 |
4D Pharma Res Ltd |
Compositions comprising bacterial strains
|
EP3380108B1
(en)
|
2015-11-24 |
2022-11-16 |
Seres Therapeutics, Inc. |
Designed bacterial compositions
|
AU2016361583B2
(en)
|
2015-11-25 |
2021-05-13 |
Memorial Sloan-Kettering Cancer Center |
Methods and compositions for reducing vancomycin-resistant enterococci infection or colonization
|
CN108779434A
(zh)
|
2016-01-11 |
2018-11-09 |
3Plw有限责任公司 |
被遗传修饰以分泌多糖降解酶的利用乳酸的细菌
|
PT3313423T
(pt)
|
2016-03-04 |
2019-07-10 |
4D Pharma Plc |
Composições que compreendem a estirpe blautia bacteriana para tratar a hipersensibilidade visceral
|
EP4368254A2
(en)
|
2016-03-14 |
2024-05-15 |
Holobiome, Inc. |
Modulation of the gut microbiome to treat mental disorders or diseases of the central nervous system
|
US9999641B2
(en)
|
2016-06-14 |
2018-06-19 |
Vedanta Biosciences, Inc. |
Treatment of clostridium difficile infection
|
JP6898628B2
(ja)
|
2016-06-15 |
2021-07-07 |
国立大学法人広島大学 |
神経変性疾患治療剤
|
TWI802545B
(zh)
|
2016-07-13 |
2023-05-21 |
英商4D製藥有限公司 |
包含細菌菌株之組合物
|
IT201600091033A1
(it)
|
2016-09-08 |
2018-03-08 |
Bioimmunizer Sagl |
Ceppi di batteri probiotici appartenenti al genere Bifidobacterium e loro estratti di cellule probiotiche (ECP) aventi proprietà immunostimolanti.
|
WO2018094190A2
(en)
|
2016-11-18 |
2018-05-24 |
Sanford Burnham Prebys Medical Discovery Institute |
Gut microbiota and treatment of cancer
|
GB201621123D0
(en)
|
2016-12-12 |
2017-01-25 |
4D Pharma Plc |
Compositions comprising bacterial strains
|
WO2018112365A2
(en)
|
2016-12-16 |
2018-06-21 |
Evelo Biosciences, Inc. |
Methods of treating colorectal cancer and melanoma using parabacteroides goldsteinii
|
WO2018112363A1
(en)
|
2016-12-16 |
2018-06-21 |
Evelo Biosciences, Inc. |
Methods of treating cancer using parabacteroides
|
CN106890196A
(zh)
|
2017-04-07 |
2017-06-27 |
青岛东海药业有限公司 |
酪酸梭菌在制备预防或治疗帕金森病制剂中的应用
|
MA41708A
(fr)
|
2017-05-24 |
2020-04-08 |
4D Pharma Res Ltd |
Compositions comprenant des souches bactériennes
|
WO2018229189A1
(en)
|
2017-06-14 |
2018-12-20 |
4D Pharma Research Limited |
Compositions comprising bacterial strains
|
HRP20220747T1
(hr)
|
2017-06-14 |
2022-10-14 |
4D Pharma Research Limited |
Pripravci koji sadrže bakterijske sojeve
|
AU2018298087A1
(en)
|
2017-07-05 |
2020-01-23 |
Evelo Biosciences, Inc. |
Compositions and methods of treating cancer using bifidobacterium animalis ssp. lactis
|
KR20210008393A
(ko)
|
2018-05-11 |
2021-01-21 |
4디 파마 리서치 리미티드 |
세균 균주를 포함하는 조성물
|
EP3893905A1
(en)
|
2018-12-12 |
2021-10-20 |
4D Pharma Research Limited |
Compositions comprising bacterial strains
|